GlobeNewswire

Kylo Peptides Strengthens U.S.-Based Supply Chain for Research Peptides with Faster Domestic Fulfillment
22/09/2026
Sheridan, Wyoming, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides [ https://kylopeptides.com/ ] has strengthened domestic fulfillment for research peptides, routing more order flow through one U.S. warehouse so [...]
Rendever Expands Dementia & Empathy Training With a New Mode for Family Caregivers
22/09/2026
New feature brings guidance from a family caregiver turned dementia researcher directly into the immersive training, helping families navigate a loved one's condition at home BOSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- [...]
Seek Labs Launches Open Impact Program at Clinton Global Initiative to Advance Therapeutic Development for Neglected Infectious Diseases
22/09/2026
New Commitment to Action will apply Seek Labs’ BioSeeker AI and Sequence Ablation Therapeutics platform to diseases historically underserved by traditional therapeutic development SALT LAKE CITY, Sept. 22, 2026 (GLOBE [...]
Ophirex Publishes Data from Phase 2 BRAVIO Trial Evaluating Intravenous Followed by Oral Varespladib for Snakebite
22/09/2026
Trial evaluated varespladib administered after antivenom across multiple snake species in India and the United States Clinically important signals of benefit observed in patients bitten by kraits and copperheads CORTE [...]
New Study Reveals When College Students at Risk for Suicide Begin to Improve in Virtual Therapy
22/09/2026
Peer-reviewed TimelyCare research published in DIGITAL HEALTH finds many students show early improvement while underscoring the need for continued suicide risk monitoring. Fort Worth, TX, Sept. 22, 2026 (GLOBE NEWSWIRE [...]
Eclipse Energy and Wood Validate Pathway to Low-Cost, Ultra-Low-Carbon Hydrogen from Depleted Oil Reservoirs
22/09/2026
RenovaStrata™ H2 achieves modeled LCOH as low as $0.56/kg and carbon intensity of 0.076 kgCO₂e/kgH₂, reinforcing potential for commercial-scale, ultra-low-carbon hydrogen HOUSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- [...]
Porch Light Health and CBHC Expand Access to Methadone Treatment in Northern Colorado
22/09/2026
New medication units in Fort Collins and Greeley bring methadone treatment into existing Porch Light Health outpatient addiction clinics DENVER, Sept. 22, 2026 (GLOBE NEWSWIRE) -- As drug overdose deaths continue to [...]
X-Chem Announces Phase 3 Milestone in Collaboration with Relay Therapeutics
22/09/2026
WALTHAM, Mass., Sept. 22, 2026 (GLOBE NEWSWIRE) -- X-Chem, a global leader in innovative drug discovery services, announced the achievement of a milestone following Relay Therapeutics’ initiation of a Phase 3 clinical [...]
Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
22/09/2026
Fasedienol nasal spray was well-tolerated in patients with social anxiety disorder with no new drug-related safety findings after as-needed use for up to 12 months Clinically relevant improvement in social anxiety over [...]
Elevar Therapeutics Receives FDA Conditional Acceptance of LYRFIGTU as Brand Name for Lirafugratinib
22/09/2026
In March, the FDA granted Priority Review of Lyrfigtu (lirafugratinib); PDUFA date of September 25, 2026 Lyrfigtu (lirafugratinib) achieved a 46% ORR, in CCA patients with FGFR2 fusion or other rearrangement Fort Lee, N [...]
Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium
22/09/2026
DOYLESTOWN, Pa., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery and development of [...]
Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria
22/09/2026
Founder and CEO Kevin Slawin, M.D., to deliver industry keynote on advancing mitochondrial-targeted geropeptide medicine Eos advancing lead candidate MitoXcel™ geropeptide PTC-2105 toward first-in-human studies for [...]
SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
22/09/2026
Agreement provides dedicated commercial channel for REZENOPY ™ across approximately 2,000 OTP (Opioid Treatment Program) Clinics and other Addiction Treatment Center Networks in the United States According to IQVIA data [...]
IMUNON Reports Independent Data Monitoring Committee Recommends Continued Phase 2 Development of IMNN-001 Following Favorable Safety Review
22/09/2026
Independent Data Monitoring Committee recommends the ongoing Phase 2 MRD study continue without modification following its review of all safety data to date No cytokine release syndrome, systemic toxicities or serious [...]
Recludix Pharma to Present at the Oppenheimer Private Life Sciences Company Showcase
22/09/2026
SAN DIEGO, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced that Nancy [...]
PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology
22/09/2026
39.3 months median overall survival in first-line (1L) R/M immune checkpoint inhibitor naïve patients Company continues to prioritize PDS0301 in metastatic colorectal cancer (mCRC) while pursuing partnership strategy [...]
Reviva to Participate in the Lytham Partners Fall 2026 Investor Conference
22/09/2026
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend the corporate presentation at https://lythampartners.com/fall2026/ [...]
Novo and UNICEF expand partnership to support a healthier start for more than 80 million children
22/09/2026
The four-year expansion will focus on childhood overweight and obesity prevention for over 80 million children across seven priority countries: Mexico, Colombia, Indonesia, the Philippines, India, Egypt and Kenya Novo [...]
Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical cases of LANDMARK™ Total Knee System
22/09/2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and has completed the first surgical cases with [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum